======= PRDX3 ======= == Gene Information == * **Official Symbol**: PRDX3 * **Official Name**: peroxiredoxin 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10935|10935]] * **UniProt**: [[https://www.uniprot.org/uniprot/P30048|P30048]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRDX3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRDX3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604769|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |AhpC-TSA| |Redoxin| |1-cysPrx C| |alkyl hydroperoxide reductase activity| |peptidyl-cysteine oxidation| |thioredoxin peroxidase activity| |protein oxidation| |cysteine-type endopeptidase inhibitor activity involved in apoptotic process| |hydrogen peroxide catabolic process| |maternal placenta development| |hydrogen peroxide metabolic process| |peptidyl-cysteine modification| |antibiotic catabolic process| |cofactor catabolic process| |maternal process involved in female pregnancy| |regulation of mitochondrial membrane potential| |cell redox homeostasis| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic process| |negative regulation of cysteine-type endopeptidase activity| |cellular oxidant detoxification| |kinase binding| |cellular detoxification| |antibiotic metabolic process| |reactive oxygen species metabolic process| |response to hydrogen peroxide| |detoxification| |cellular response to reactive oxygen species| |drug catabolic process| |placenta development| |positive regulation of NF-kappaB transcription factor activity| |female pregnancy| |protein C-terminus binding| |response to reactive oxygen species| |multi-multicellular organism process| |cellular response to toxic substance| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |myeloid cell differentiation| |cellular response to oxidative stress| |regulation of cysteine-type endopeptidase activity| |negative regulation of endopeptidase activity| |negative regulation of kinase activity| |negative regulation of peptidase activity| |early endosome| |positive regulation of DNA-binding transcription factor activity| |negative regulation of transferase activity| |response to antibiotic| |response to lipopolysaccharide| |response to molecule of bacterial origin| |negative regulation of proteolysis| |mitochondrial matrix| |response to oxidative stress| |regulation of endopeptidase activity| |reproductive structure development| |regulation of DNA-binding transcription factor activity| |reproductive system development| |regulation of membrane potential| |cofactor metabolic process| |mitochondrion organization| |regulation of peptidase activity| |negative regulation of phosphorylation| |negative regulation of hydrolase activity| |protein kinase binding| |drug metabolic process| |response to toxic substance| |response to inorganic substance| |hemopoiesis| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |protein-containing complex| |hematopoietic or lymphoid organ development| |immune system development| |developmental process involved in reproduction| |response to bacterium| |regulation of proteolysis| |negative regulation of catalytic activity| |multicellular organismal reproductive process| |multicellular organism reproduction| |response to lipid| |regulation of kinase activity| |peptidyl-amino acid modification| |negative regulation of apoptotic process| |cellular homeostasis| |negative regulation of programmed cell death| |positive regulation of cell population proliferation| |apoptotic process| |oxidation-reduction process| |regulation of transferase activity| |multi-organism reproductive process| |negative regulation of cell death| |response to drug| |negative regulation of cellular protein metabolic process| |programmed cell death| |cellular response to oxygen-containing compound| |identical protein binding| |cell death| |negative regulation of protein metabolic process| |negative regulation of molecular function| |mitochondrion| |regulation of hydrolase activity| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |reproductive process| |reproduction| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of phosphorylation| |regulation of cell population proliferation| |homeostatic process| |regulation of cell death| |cellular response to stress| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15518 * **Expression level (log2 read counts)**: 7.1 {{:chemogenomics:nalm6 dist.png?nolink |}}